Esprolol

CAS No. 396654-09-4

Esprolol( —— )

Catalog No. M34244 CAS No. 396654-09-4

Esprolol (ACC-9369 free base) is a novel β-adrenergic receptor antagonist for the study of exertional angina.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 196 Get Quote
5MG 300 Get Quote
10MG 445 Get Quote
25MG 707 Get Quote
50MG 994 Get Quote
100MG 1305 Get Quote
500MG 2601 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Esprolol
  • Note
    Research use only, not for human use.
  • Brief Description
    Esprolol (ACC-9369 free base) is a novel β-adrenergic receptor antagonist for the study of exertional angina.
  • Description
    Esprolol (ACC-9369 free base) is a novel β-adrenergic receptor antagonist for the study of exertional angina.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    396654-09-4
  • Formula Weight
    309.4
  • Molecular Formula
    C17H27NO4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C[C@H](CNC(C)C)O)C1=C(CCC(OCC)=O)C=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • MK-4618

    A potent and selective full β3 adrenergic receptor agonist with EC50 of 1.1 nM; displays no activity for β1 and β2 receptors (EC50>20 uM).

  • Cyclazosin HCl

    Cyclazosin HCl is a subtype-selective α-adrenergic receptor antagonist that competitively antagonizes norepinephrine-induced α(1B)-adrenergic receptor contraction and can be used to study non-arteritic ischemic optic neuropathy and other neurological diseases.

  • Nemazoline Free Base

    Nemazoline Free Base acts as an α1-adrenergic agonist and an α2-adrenergic antagonist, and may be used in the treatment of trace amine-associated receptor-related disorders.